Related Experiment Video
Updated: May 14, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Antibiotics as part of the management of severe acute malnutrition
Indi Trehan1, Hayley S Goldbach, Lacey N LaGrone
1Department of Pediatrics, Washington University in St. Louis, St. Louis, MO 63110, USA.
Insights
Adding antibiotics like amoxicillin or cefdinir to standard treatment significantly improved recovery and reduced mortality in children with severe acute malnutrition. This finding offers a crucial strategy for combating childhood malnutrition globally.
Area of Science:
- Pediatric Infectious Diseases
- Global Child Health
- Nutritional Science
Background:
- Severe acute malnutrition (SAM) is a leading cause of child mortality, responsible for approximately 1 million deaths annually.
- Routine antibiotic administration alongside nutritional therapy may enhance recovery and reduce mortality in SAM cases treated on an outpatient basis.
Purpose of the Study:
- To evaluate the efficacy of amoxicillin and cefdinir, in addition to therapeutic food, on nutritional recovery and mortality rates in children with severe acute malnutrition.
- To compare the outcomes of amoxicillin and cefdinir treatment against a placebo in the outpatient management of uncomplicated SAM.
Main Methods:
- A randomized, double-blind, placebo-controlled trial was conducted involving 2767 Malawian children aged 6 to 59 months with SAM.
- Participants received ready-to-use therapeutic food plus either amoxicillin, cefdinir, or a placebo for 7 days.
Main Results:
- Nutritional recovery rates were 88.7% for amoxicillin, 90.9% for cefdinir, and 85.1% for placebo.
- Mortality rates were 4.8% (amoxicillin), 4.1% (cefdinir), and 7.4% (placebo), with antibiotics showing significant risk reduction.
- Children receiving antibiotics exhibited increased weight gain post-recovery.
Conclusions:
- The addition of antibiotics to nutritional therapy significantly improved recovery rates and reduced mortality in children with uncomplicated severe acute malnutrition.
- Antibiotic treatment represents a valuable adjunct to standard therapeutic regimens for SAM, potentially saving lives and improving outcomes.
Background:
Severe acute malnutrition contributes to 1 million deaths among children annually. Adding routine antibiotic agents to nutritional therapy may increase recovery rates and decrease mortality among children with severe acute malnutrition treated in the community.
Methods:
In this randomized, double-blind, placebo-controlled trial, we randomly assigned Malawian children, 6 to 59 months of age, with severe acute malnutrition to receive amoxicillin, cefdinir, or placebo for 7 days in addition to ready-to-use therapeutic food for the outpatient treatment of uncomplicated severe acute malnutrition. The primary outcomes were the rate of nutritional recovery and the mortality rate.
Results:
A total of 2767 children with severe acute malnutrition were enrolled. In the amoxicillin, cefdinir, and placebo groups, 88.7%, 90.9%, and 85.1% of the children recovered, respectively (relative risk of treatment failure with placebo vs. amoxicillin, 1.32; 95% confidence interval [CI], 1.04 to 1.68; relative risk with placebo vs. cefdinir, 1.64; 95% CI, 1.27 to 2.11). The mortality rates for the three groups were 4.8%, 4.1%, and 7.4%, respectively (relative risk of death with placebo vs. amoxicillin, 1.55; 95% CI, 1.07 to 2.24; relative risk with placebo vs. cefdinir, 1.80; 95% CI, 1.22 to 2.64). Among children who recovered, the rate of weight gain was increased among those who received antibiotics. No interaction between type of severe acute malnutrition and intervention group was observed for either the rate of nutritional recovery or the mortality rate.
Conclusions:
The addition of antibiotics to therapeutic regimens for uncomplicated severe acute malnutrition was associated with a significant improvement in recovery and mortality rates. (Funded by the Hickey Family Foundation and others; ClinicalTrials.gov number, NCT01000298.).
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
03:25Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Clinical Significance of Antibiotic Resistance
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Tonsillitis II: Management